Jackson Creek Investment Advisors LLC bought a new stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 9,204 shares of the medical instruments supplier's stock, valued at approximately $1,428,000.
Other large investors also recently modified their holdings of the company. Arizona State Retirement System grew its holdings in shares of ICU Medical by 1.0% during the 4th quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock worth $1,044,000 after acquiring an additional 65 shares during the period. Equitable Trust Co. lifted its holdings in ICU Medical by 1.6% during the fourth quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock valued at $822,000 after purchasing an additional 84 shares in the last quarter. Connable Office Inc. boosted its stake in shares of ICU Medical by 6.4% in the third quarter. Connable Office Inc. now owns 2,031 shares of the medical instruments supplier's stock worth $370,000 after acquiring an additional 122 shares during the period. Gagnon Securities LLC boosted its holdings in shares of ICU Medical by 0.5% during the 4th quarter. Gagnon Securities LLC now owns 28,881 shares of the medical instruments supplier's stock valued at $4,481,000 after purchasing an additional 137 shares during the last quarter. Finally, Wealthspire Advisors LLC increased its position in ICU Medical by 6.4% in the fourth quarter. Wealthspire Advisors LLC now owns 2,660 shares of the medical instruments supplier's stock worth $413,000 after purchasing an additional 160 shares during the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on ICUI shares. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research report on Wednesday, November 13th. KeyCorp boosted their price target on ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 13th. Jefferies Financial Group raised ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target for the company in a research report on Wednesday, December 11th. Finally, StockNews.com cut shares of ICU Medical from a "buy" rating to a "hold" rating in a research note on Monday. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $199.67.
Get Our Latest Analysis on ICU Medical
ICU Medical Stock Performance
NASDAQ:ICUI traded up $8.94 during trading hours on Tuesday, reaching $138.99. The company had a trading volume of 414,974 shares, compared to its average volume of 231,417. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical, Inc. has a 1-year low of $93.36 and a 1-year high of $196.26. The business's 50 day moving average price is $158.56 and its 200-day moving average price is $165.59. The firm has a market cap of $3.41 billion, a PE ratio of -30.41 and a beta of 0.73.
Insider Activity at ICU Medical
In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the firm's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the sale, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at approximately $16,262,119.64. This trade represents a 1.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 6.70% of the company's stock.
About ICU Medical
(
Free Report)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
Read More
Before you consider ICU Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.
While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
